封面
市場調查報告書
商品編碼
1291620

腎癌治療和診斷市場2023-2028年按成分、癌症類型、應用和地區分類

Kidney Cancer Therapeutics and Diagnostics Market by Component, Cancer Types, Application, and Region 2023-2028

出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

全球腎癌治療和診斷市場規模在2022年達到47.2億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到71.7億美元,在2023-2028年期間,成長率(CAGR)為7.12%。腎癌發病率的上升,老年人口的增加,以及一些政府的有利計劃代表了推動市場的一些關鍵因素。

腎癌是一種慢性疾病,腎臟組織中出現異常的細胞生長,從而變成腫瘤。其症狀包括血尿、食慾不振、腹痛、疲倦、發燒、體重減輕、骨痛、高血壓和貧血。腎癌可通過各種技術進行診斷,如血液和尿液檢查、活體組織切片、生物標記檢測、電腦斷層掃描(CT)、X光、磁共振成像(MRI)、膀胱鏡和腎臟輸尿管鏡檢查。它可以通過藥物、化療、放療、腎切除、冷凍消融、射頻消融和靶向治療來治療。腎癌治療方法和診斷方法有助於清除癌細胞,摧毀腫瘤和防止複發,並協助醫生規劃治療。它們還有助於改善腎臟功能,減少未來的併發症,控制癌症擴散,並提高病人的舒適度。

腎癌治療和診斷的市場趨勢:

由於吸煙習慣、肥胖、遺傳條件和接觸化學品等因素的日益普遍,腎癌的發病率不斷上升,這是推動市場成長的主要因素之一。腎癌治療和診斷方法被廣泛用於分析和治療腎細胞癌(RCC)、良性腎臟腫瘤、威爾姆斯腫瘤、過渡性細胞癌、腎臟肉瘤、髓樣癌、多囊性RCC以及粘液性管狀和紡錘形細胞癌。此外,對腎細胞癌和其他形式的腎癌具有高度敏感性的老年人口的增加,促進了對治療和診斷的需求,以管理腫瘤,延長生存期,並保留腎臟的非癌變部分。此外,最近開發的能夠檢測生物標記的診斷工具,如含有5的桿狀病毒IAP重複(BIRC5),是早期檢測透明細胞RCC和預測病人預後的關鍵指標,正在積極地影響市場的成長。除此之外,引入3D(3D)列印技術來創建腎臟及其腫瘤的術前模型,進而幫助醫生製定治療計劃,為患者提供適當的諮詢,減少手術錯誤,提高效率,並保留大部分腎臟功能,這些都有利於市場的成長。此外,政府實施各種計劃來傳播有關癌症的意識,正在為市場創造一個積極的前景。其他因素,包括醫療保健行業的顯著成長,為確定潛在的治療方案而對研究和開發(R&D)活動的投資增加,以及先進技術的廣泛採用,如機器人手術、遠程醫療和人工智慧(AI),預計將進一步推動市場成長。

本報告中回答的關鍵問題:

  • 迄今為止,全球腎癌治療和診斷市場的表現如何,在未來幾年將如何表現?
  • 全球腎癌治療和診斷市場的驅動因素、限制因素和機會是什麼?
  • 主要的區域市場是什麼?
  • 哪些國家代表了最有吸引力的腎癌治療和診斷市場?
  • 基於組件的市場細分是什麼?
  • 基於癌症類型的市場細分是什麼?
  • 基於應用的市場細分是什麼?
  • 全球腎癌治療和診斷市場的競爭結構是什麼?
  • 誰是全球腎癌治療和診斷市場的主要參與者/公司?

目錄

第一章:前言

第二章:範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章:執行摘要

第四章:簡介

  • 概述
  • 主要行業趨勢

第五章:全球腎癌治療和診斷市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章:按成分分類的市場

  • 藥品
    • 市場趨勢
    • 關鍵部分
      • 按治療類別分類的藥物
      • 靶向治療
      • 免疫療法
      • 其他藥物
      • 按藥理類別分類的藥物
      • 血管生成抑製劑
      • mTOR抑製劑
      • 單克隆抗體
      • 細胞因子免疫療法(II-2)
    • 市場預測
  • 診斷學
    • 市場趨勢
    • 關鍵領域
      • 影像測試
      • 生物檢查
      • 血液測試
      • 其他
    • 市場預測

第七章:按癌症類型分類的市場

  • 透明細胞RCC
    • 市場趨勢
    • 市場預測
  • 乳頭狀RCC
    • 市場趨勢
    • 市場預測
  • 嗜鉻細胞性紅斑狼瘡
    • 市場趨勢
    • 市場預測
  • 過渡性細胞癌
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第8章:按應用分類的市場

  • 醫院
    • 市場趨勢
    • 市場預測
  • 醫藥實驗室
    • 市場趨勢
    • 市場預測
  • 基因組學實驗室
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章:按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十章:驅動因素、限制因素和機會

  • 概述
  • 驅動因素
  • 限制因素
  • 機會

第十一章:價值鏈分析

第十二章:波特斯五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十三章:價格分析

第十四章:競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的簡介
    • Bristol-Myers Squibb Company
    • Exelixis Inc.
    • Genentech Inc. (Roche Holding AG)
    • Novartis AG
    • Pfizer Inc.

請注意,這只代表部分公司的名單,完整的名單已在報告中提供。

Product Code: SR112023A7528

The global kidney cancer therapeutics and diagnostics market size reached US$ 4.72 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.17 Billion by 2028, exhibiting a growth rate (CAGR) of 7.12% during 2023-2028. The rising incidences of kidney cancer, increasing geriatric population, and favorable initiatives by several governments represent some of the key factors driving the market.

Kidney cancer is a chronic disease where abnormal cell growth occurs in kidney tissues, which turns into tumors. Its symptoms include blood in urine, loss of appetite, flank pain, tiredness, fever, weight loss, bone pain, high blood pressure, and anemia. Kidney cancer is diagnosed through various techniques, such as blood and urine tests, biopsy, biomarker testing, computed tomography (CT) scan, X-ray, magnetic resonance imaging (MRI), cystoscopy, and nephron-ureteroscopy. It can be treated through medications, chemotherapy, radiation therapy, nephrectomy, cryoablation, radiofrequency ablation, and targeted therapy. Kidney cancer therapeutics and diagnostics aid in the removal of cancer cells, destroy tumors and prevent recurring, and assist physicians in planning treatments. They also help in improving kidney function, reducing future complications, controlling cancer spread, and enhancing patient comfort.

Kidney Cancer Therapeutics and Diagnostics Market Trends:

The rising incidences of kidney cancer due to the increasing prevalence of smoking habits, obesity, genetic conditions, and exposure to chemicals is one of the primary factors driving the market growth. Kidney cancer therapeutics and diagnostics are widely used to analyze and treat renal cell carcinoma (RCC), benign kidney tumors, Wilms tumors, transitional cell cancer, renal sarcoma, medullary carcinoma, multilocular cystic RCC, and mucinous tubular and spindle cell carcinoma. Furthermore, the rising geriatric population with high susceptibility to renal cell carcinoma and other forms of kidney cancer is facilitating the demand for therapeutics and diagnostics to manage tumors, prolong survival, and preserve noncancerous parts of the kidney. Additionally, the recent development of diagnostic tools capable of detecting biomarkers, such as baculoviral IAP repeat containing 5 (BIRC5), a key indicator for early detection of clear cell RCC and predicting patient prognosis, is positively influencing the market growth. Apart from this, the introduction of three-dimensional (3D) printing to create pre-operative models of the kidney and its tumors, which, in turn, aids physicians in treatment planning and providing appropriate counseling to the patients, reducing surgical errors, enhancing efficiency, and preserving the majority of kidney functions are favoring the market growth. Moreover, the implementation of various government initiatives to spread awareness regarding cancer is creating a positive outlook for the market. Other factors, including significant growth in the healthcare industry, rising investment in research and development (R&D) activities to identify potential treatment options, and widespread adoption of advanced technologies, such as robotic surgery, telemedicine, and artificial intelligence (AI), are anticipated to drive the market growth further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global kidney cancer therapeutics and diagnostics market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on component, cancer types, and application.

Component Insights:

Drugs

Drugs by Therapeutic Class

Targeted Therapy

Immunotherapy

Others

Drugs by Pharmacologic Class

Angiogenesis Inhibitors

mTOR Inhibitors

Monoclonal Antibodies

Cytokine Immunotherapy (II-2)

Diagnostics

Imaging Test

Biopsy

Blood Test

Others

The report has also provided a detailed breakup and analysis of the kidney cancer therapeutics and diagnostics market based on the component. This includes drugs (therapeutic class (targeted therapy, immunotherapy, and others) and pharmacological class (angiogenesis inhibitors, mTOR inhibitors, monoclonal antibodies, and cytokine immunotherapy (II-2))) and diagnostics (imaging test, biopsy, blood test, and others). According to the report, drugs represented the largest segment.

Cancer Types Insights:

Clear Cell RCC

Papillary RCC

Chromophobe RCC

Transitional Cell Carcinoma

Others

A detailed breakup and analysis of the kidney cancer therapeutics and diagnostics market based on the cancer types has been provided in the report. This includes clear cell RCC, papillary RCC, chromophobe RCC, transitional cell carcinoma, and others. According to the report, clear cell RCC accounted for the largest market share.

Application Insights:

Hospitals

Pharmaceutical Labs

Genomic Laboratories

Others

A detailed breakup and analysis of the kidney cancer therapeutics and diagnostics market based on the application has been provided in the report. This includes hospitals, pharmaceutical labs, genomic laboratories, and others. According to the report, hospitals accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for kidney cancer therapeutics and diagnostics. Some of the factors driving the North America kidney cancer therapeutics and diagnostics market include increasing incidences of kidney cancer, rising research and development (R&D) expenditure, increasing geriatric population, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global kidney cancer therapeutics and diagnostics market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Bristol-Myers Squibb Company, Exelixis Inc., Genentech Inc. (Roche Holding AG), Novartis AG, Pfizer Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global kidney cancer therapeutics and diagnostics market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global kidney cancer therapeutics and diagnostics market?
  • What are the key regional markets?
  • Which countries represent the most attractive kidney cancer therapeutics and diagnostics markets?
  • What is the breakup of the market based on the component?
  • What is the breakup of the market based on the cancer types?
  • What is the breakup of the market based on the application?
  • What is the competitive structure of the global kidney cancer therapeutics and diagnostics market?
  • Who are the key players/companies in the global kidney cancer therapeutics and diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Kidney Cancer Therapeutics and Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Drugs by Therapeutic Class
      • 6.1.2.1.1 Targeted Therapy
      • 6.1.2.1.2 Immunotherapy
      • 6.1.2.1.3 Others
      • 6.1.2.2 Drugs by Pharmacologic Class
      • 6.1.2.2.1 Angiogenesis Inhibitors
      • 6.1.2.2.2 mTOR Inhibitors
      • 6.1.2.2.3 Monoclonal Antibodies
      • 6.1.2.2.4 Cytokine Immunotherapy (II-2)
    • 6.1.3 Market Forecast
  • 6.2 Diagnostics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Imaging Test
      • 6.2.2.2 Biopsy
      • 6.2.2.3 Blood Test
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Cancer Types

  • 7.1 Clear Cell RCC
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Papillary RCC
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Chromophobe RCC
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Transitional Cell Carcinoma
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Genomics Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Bristol-Myers Squibb Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Exelixis Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Genentech Inc. (Roche Holding AG)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Novartis AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Pfizer Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Kidney Cancer Therapeutics and Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Kidney Cancer Therapeutics and Diagnostics Market: Breakup by Component (in %), 2022
  • Figure 5: Global: Kidney Cancer Therapeutics and Diagnostics Market: Breakup by Cancer Types (in %), 2022
  • Figure 6: Global: Kidney Cancer Therapeutics and Diagnostics Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Kidney Cancer Therapeutics and Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Kidney Cancer Therapeutics and Diagnostics (Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Kidney Cancer Therapeutics and Diagnostics (Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Kidney Cancer Therapeutics and Diagnostics (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Kidney Cancer Therapeutics and Diagnostics (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Kidney Cancer Therapeutics and Diagnostics (Clear Cell RCC) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Kidney Cancer Therapeutics and Diagnostics (Clear Cell RCC) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Kidney Cancer Therapeutics and Diagnostics (Papillary RCC) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Kidney Cancer Therapeutics and Diagnostics (Papillary RCC) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Kidney Cancer Therapeutics and Diagnostics (Chromophobe RCC) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Kidney Cancer Therapeutics and Diagnostics (Chromophobe RCC) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Kidney Cancer Therapeutics and Diagnostics (Transitional Cell Carcinoma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Kidney Cancer Therapeutics and Diagnostics (Transitional Cell Carcinoma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Kidney Cancer Therapeutics and Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Kidney Cancer Therapeutics and Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Kidney Cancer Therapeutics and Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Kidney Cancer Therapeutics and Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Kidney Cancer Therapeutics and Diagnostics (Pharmaceutical Labs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Kidney Cancer Therapeutics and Diagnostics (Pharmaceutical Labs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Kidney Cancer Therapeutics and Diagnostics (Genomics Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Kidney Cancer Therapeutics and Diagnostics (Genomics Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Kidney Cancer Therapeutics and Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Kidney Cancer Therapeutics and Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Kidney Cancer Therapeutics and Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Kidney Cancer Therapeutics and Diagnostics Industry: Drivers, Restraints, and Opportunities
  • Figure 80: Global: Kidney Cancer Therapeutics and Diagnostics Industry: Value Chain Analysis
  • Figure 81: Global: Kidney Cancer Therapeutics and Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Kidney Cancer Therapeutics and Diagnostics Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Component (in Million US$), 2023-2028
  • Table 3: Global: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Cancer Types (in Million US$), 2023-2028
  • Table 4: Global: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Kidney Cancer Therapeutics and Diagnostics Market: Competitive Structure
  • Table 7: Global: Kidney Cancer Therapeutics and Diagnostics Market: Key Players